The evolving pharmaceutical landscape presents distinct challenges and avenues. Innovative technologies, such as artificial intelligence and precision medicine, are redefining treatment innovation and dispensation. Furthermore, growing pressure on pricing and legal structures necessitate a planned tactic from firms. Successfully tackling this compl